Leslie Pace
Payments from drug & device makers
Across 279 payments — averaging $17.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- AstraZeneca$688
- GSK$428
- Pfizer$366
- Boehringer Ingelheim$264
- Novo Nordisk$249
- plus $2K from 24 others
What the payments were for
- Food & beverage$4,997100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 89 | $1,373 |
| AstraZeneca | 29 | $688 |
| GSK | 21 | $428 |
| Pfizer | 20 | $366 |
| Boehringer Ingelheim | 14 | $264 |
| Novo Nordisk | 11 | $249 |
| Lilly USA, LLC | 10 | $187 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $185 |
| Astellas Pharma US Inc | 9 | $184 |
| Biohaven Pharmaceutical Holding Company Ltd. | 18 | $153 |
| Corcept Therapeutics | 6 | $124 |
| Merck | 5 | $108 |
| Dexcom, Inc. | 5 | $90 |
| Idorsia Pharmaceuticals US Inc | 5 | $82 |
| Scilex Pharmaceuticals Inc. | 3 | $71 |
| Amgen | 3 | $70 |
| Lundbeck LLC | 2 | $55 |
| Biohaven Pharmaceuticals, Inc. | 2 | $41 |
| Vanda Pharmaceuticals Inc. | 2 | $39 |
| Verity Pharmaceuticals Inc. | 2 | $39 |
| Xeris Pharmaceuticals, Inc. | 2 | $35 |
| Bayer | 2 | $29 |
| Kowa Pharmaceuticals America, Inc. | 1 | $23 |
| Harmony Biosciences LLC | 1 | $22 |
| Ironwood Pharmaceuticals, Inc | 1 | $22 |
| Eisai Inc. | 1 | $22 |
| Boston Scientific | 1 | $18 |
| Abbott | 1 | $15 |
| Biocryst US Sales Co., LLC | 1 | $12 |
| Phathom Pharmaceuticals, Inc. | 1 | $5 |
How this compares
$4,997 in reported general payments places this provider in the 90th percentile of 1,501 family providers in Nevada.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 42 | $43,130 |
| Nurtec OdtRimegepant Sulfate | 11 | $23,417 |
| MounjaroTirzepatide | 20 | $23,114 |
| JardianceEmpagliflozin | 12 | $16,489 |
| EliquisApixaban | 15 | $15,383 |
| OzempicSemaglutide | 14 | $12,959 |
| Estradiol (Twice Weekly)Estradiol | 16 | $1,882 |
| Estradiol | 22 | $1,787 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 63 | $1,693 |
| Levothyroxine Sodium | 110 | $1,376 |
| Gabapentin | 71 | $1,288 |
| Atorvastatin Calcium | 86 | $1,214 |
| Omeprazole | 51 | $1,178 |
| Rosuvastatin Calcium | 68 | $1,083 |
| Duloxetine Hcl | 25 | $1,016 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $688 | $43,13042 claims |
| PfizerNurtec Odt, Eliquis | $366 | $38,80126 claims |
| Lilly USA, LLCMounjaro | $187 | $23,11420 claims |
| Boehringer IngelheimJardiance | $264 | $16,48912 claims |
| Novo NordiskOzempic | $249 | $12,95914 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,501 family providers in Nevada.
Other family in Reno
- Lisa Hammargren-KuykendallReno$22K
- Martha AiyukReno$15K
- Jocelyn AllenReno$12K
- Kaylie HumphreysReno$11K
- Christina KrainbrinkReno$10K
- Barbara SzatkowskiReno$10K
- Johanna LeeReno$9K
- Darin OldeReno$9K
- Ruth SkinnerReno$8K
- Anna EllisReno$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.